Latest News by Industry
MADISON, Wis. (AP) — MADISON, Wis. (AP) — Exact Sciences Corp. (EXAS) on Tuesday reported a loss of $74.2 million in its first quarter.
The Madison, Wisconsin-based company said it had a loss of 42 cents per share.
The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 79 cents per share.
The molecular diagnostics company posted revenue of $602.5 million in the period, also beating Street forecasts. Eight analysts surveyed by Zacks expected $542.5 million.
Exact Sciences expects full-year revenue in the range of $2.38 billion to $2.42 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a EXAS">Zacks stock report on EXAS at https://www.zacks.com/ap/EXAS